top of page
.png){kind=logo}
™
Heligenics believes that people can live healthier lives. We recognize major healthcare problems can be solved through advanced analysis of the function of genetic variation. Do you want to modernize and improve healthcare with us?
​
Heligenics analyzes a gene mutation library (GML) with the GigaAssay™ to produce a comprehensive mutation effect on gene activity map (MEGA-Map™)
Problems
-
​Diagnostics tests target less than one percent of mutations
-
Precision drugs target only a fraction of potential responders
-
Clinical trials fail because they enroll non-responders
-
Biologic drugs are rarely engineered for potency or safety
-
Bifunctional Therapies are decade long development process
Current Approach
Companies identify variants through clinical associations with disease or drug therapy. Low throughput approaches are used to validate variants.
Our Solutions
-
Diagnostics based upon all mutations
-
Genetically-selected, truly precision drugs by testing all mutations​
-
Eliminate non-responders before clinical trials
-
Rapidly re-design existing Biologics and engineer new Biologics with improved efficacy and safety
-
Rapid large scale screen for 10,000's of multifunction agonists and antagonist chimeras in human cells
WHAT WE DO
At Heligenics we produce all genetic variants and test their functional impact en masse in live human cells by delivering Improved Diagnostics, Faster and Better Companion Diagnostics, Truly Precision Clinical Trials, and Novel Biologics and Biobetters
"Directly testing cell & molecular functions is the key to pathology and drug discovery"
Martin Schiller, CEO; Heligenics
bottom of page